Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Urticaria
ADR ID BADD_A04469
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.06      Urticarias
10.01.06.001      Urticaria
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.02      Urticarias
23.04.02.001      Urticaria
Description A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins. [CTCAE] A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. [MeSH]
MedDRA Code 10046735
MeSH ID D014581
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic urticaria | Acute urticaria | Allergic urticaria | Erythema urticarial | Generalised urticarial | Generalised urticarial rash | Histamine-like rash | Hives | Nettle rash | Other specified urticaria | Pharmacological urticaria | Rash urticaria-like | Rash urticarial | Subcutaneous urticaria | Unspecified urticaria | Urticaria | Urticaria acute | Urticaria aggravated | Urticaria NOS | Urticaria subcutaneous | Urticaria, unspecified | Urticarial | Urticarial rash | Urticarial symptom | Urticated rash | Urtication | Welts | Wheals | Generalized urticaria | Urticaria generalised | Urticaria drug-induced | Urticaria localised | Urticaria localized | Generalized urticarial rash | Urticaria recurrent | Generalised urticaria | Atopic urticaria | Urticarias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01571Nitazoxanide0.000963%
BADD_D01575Nitrite--
BADD_D01576Nitrofurantoin0.000121%
BADD_D01577Nitrofurantoin (macrocrystals)--
BADD_D01578Nitrofurantoin (monohydrate/macrocrystals)--
BADD_D01579Nitroglycerin--
BADD_D01582Nizatidine--
BADD_D01585Norethindrone--
BADD_D01586Norethindrone acetate--
BADD_D01587Norfloxacin--
BADD_D01588Nortriptyline--
BADD_D01589Nortriptyline hydrochloride--
BADD_D01590Nuvaring--
BADD_D01591Nystatin--
BADD_D01592Obeticholic acid0.017514%
BADD_D01593Obiltoxaximab--
BADD_D01595Octreotide acetate--
BADD_D01596Ofatumumab--
BADD_D01598Ofloxacin0.000125%
BADD_D01599Olanzapine--
BADD_D01600Olanzapine pamoate--
BADD_D01602Olmesartan--
BADD_D01603Olmesartan medoxomil--
BADD_D01607Olsalazine--
BADD_D01609Omacetaxine mepesuccinate0.000571%
BADD_D01610Omalizumab--
BADD_D01614Omeprazole0.000030%
BADD_D01615Omeprazole magnesium--
BADD_D01617Ondansetron0.000054%
BADD_D01618Ondansetron hydrochloride--
The 30th Page    First    Pre   30 31 32 33 34    Next   Last    Total 45 Pages
ADReCS-Target
ADR Term Drug Name Target